Therapeutic potential of TGF-beta inhibition in chronic renal failure.
about
Heme oxygenase-1 as a target for TGF-β in kidney diseaseCombinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 proteinThe attenuation of renal fibrosis by histone deacetylase inhibitors is associated with the plasticity of FOXP3+IL-17+ T cellsIn rat renal fibroblasts, mycophenolic acid inhibits proliferation and production of the chemokine CCL2, stimulated by tumour necrosis factor-alpha.A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal FibrosisMyostatin directly regulates skeletal muscle fibrosis.Amelioration of glomerulosclerosis with all-trans retinoic acid is linked to decreased plasminogen activator inhibitor-1 and α-smooth muscle actin.New renal drug development to face chronic renal disease.Available and incoming therapies for idiopathic focal and segmental glomerulosclerosis in adults.Rutin ameliorates renal fibrosis and proteinuria in 5/6-nephrectomized rats by anti-oxidation and inhibiting activation of TGFβ1-smad signaling.Thymosin β4 alleviates renal fibrosis and tubular cell apoptosis through TGF-β pathway inhibition in UUO rat models.A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren.Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.Antifibrotic effects of pirfenidone in rat proximal tubular epithelial cells.
P2860
Q26998726-92D63814-FE26-4FDF-AE2C-2D203183A32AQ33320906-2224EBD9-71A7-4329-B1CA-08264E0ABE51Q33892797-9146BE57-4C64-45E0-AEDC-9EF326701D19Q34116774-54D3FB39-C3C5-47DA-8711-40B38BE8EDEAQ35669295-38B3AB64-9765-4611-AADC-67CEF35F3633Q35903075-E7621020-0667-462A-8415-7E0C36689801Q36744190-2EB6D35F-9645-4444-BC74-5EFC73480C06Q37729850-AA0C4124-69B8-45E2-B5F6-BFB654B2381DQ38246640-FF3A640C-C2B2-4411-8369-3ACA4ECD7F25Q38805701-9956DF46-DCFD-4867-B8C5-4DB050068A4BQ41642566-C3EB8A73-21EC-42CE-AD0E-FD2608DEB057Q42672184-A7B0935E-0FBD-4C5A-BAAA-26CF94DB6836Q42946276-F4317C11-A3E3-4A89-BDA7-2A8E3280834BQ46662758-EB359153-D473-430B-8F9D-80D083419E87Q54481748-8502641D-863E-45C9-BD00-492BC8387488
P2860
Therapeutic potential of TGF-beta inhibition in chronic renal failure.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic potential of TGF-beta inhibition in chronic renal failure.
@ast
Therapeutic potential of TGF-beta inhibition in chronic renal failure.
@en
type
label
Therapeutic potential of TGF-beta inhibition in chronic renal failure.
@ast
Therapeutic potential of TGF-beta inhibition in chronic renal failure.
@en
prefLabel
Therapeutic potential of TGF-beta inhibition in chronic renal failure.
@ast
Therapeutic potential of TGF-beta inhibition in chronic renal failure.
@en
P2860
P356
P1476
Therapeutic potential of TGF-beta inhibition in chronic renal failure.
@en
P2093
Ariela Benigni
Elena Gagliardini
P2860
P304
P356
10.1517/14712598.7.3.293
P407
P577
2007-03-01T00:00:00Z